Equitec Proprietary Markets’s BioTelemetry, Inc. BEAT Stock Holding History

Equitec Proprietary Markets’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$548K	Buy	+7,600	New	+$398K	0.14%	51

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return

SGCM

Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Equitec Proprietary Markets's BEAT Position: Q4 2020 in Review

Equitec Proprietary Markets opened a new position in BioTelemetry, Inc. (BEAT) in Q4 2020: 7,600 shares worth $548K. The stake represents 0.14% of the portfolio and ranks #51 among its holdings.

238 funds tracked by Wall St. Rank hold BEAT as of Q4 2020.

Equitec Proprietary Markets held 7,600 shares of BioTelemetry, Inc. worth $548K as of Q4 2020.
BioTelemetry, Inc. was a new Equitec Proprietary Markets position in Q4 2020.
BioTelemetry, Inc. made up 0.14% of Equitec Proprietary Markets's portfolio in Q4 2020, its #51 holding.
238 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2020.

Based on Equitec Proprietary Markets's 13F filing for Q4 2020, filed 26 Jan 2021.